August 29, 2022
New research looks at the potential benefits of long-term statin use in patients who are at increased risk of cardiovascular disease.
August 24, 2022
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.
August 22, 2022
Lack of blood clotting may afford some protection against common cardiovascular disease events, such as ischemic stroke.
August 10, 2022
New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
July 06, 2022
An analysis of nationally representative data from NHANES cycles from 1999-2000 through 2017-2018 suggests just 6.8% of US adults had optimal cardiometabolic health.
July 05, 2022
Hypertension adversely impacts the multiple sclerosis (MS) disease course and is more common among Black Americans.
June 24, 2022
The American College of Cardiology and patient groups pushed the PBM to reverse its decision to take Eliquis off its formularies. CVS Caremark says it changed course after negotiating a lower net price.
May 10, 2022
An analysis of data from a Cleveland Clinic database indicates calcium supplementation in older adults with aortic stenosis was linked to an increased risk of mortality and worsening aortic stenosis.
April 06, 2022
Class 1C antiarrhythmic drugs were associated with the lowest rate of adverse outcomes.
March 01, 2022
The approval indicates the SGLT2 inhibitor for reducing risk of CV death and hospitalizations for heart failure in adults with heart failure.
